- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Deal Volume Takes Hit But Value of Healthcare Transactions Climbs
Healthcare firms completed fewer deals in the second quarter of this year compared with the prior quarter, but the overall value of the transactions surged on the heels of a number of blockbuster tie-ups.
Read the full story: http://bit.ly/NOEXI2
Source: ModernHealthcare.com
In total, the healthcare industry completed 321 deals in the second quarter, a 20% decrease compared with the 401 deals recorded in the first three months of the year. But acquirers put more money on the table, with the value of disclosed deals jumping 214.7% to reach $50.6 billion compared with $16.1 billion in the first quarter, according to Healthcare M&A Watch, Modern Healthcare's new quarterly report on healthcare merger and acquisition activity.
Survival, PROs Favor Cemiplimab Plus Chemotherapy vs Chemotherapy Alone in Advanced NSCLC
December 4th 2023For patients with advanced non–small cell lung cancer (NSCLC), regardless of PD-L1 status, cemiplimab plus chemotherapy had favorable survival benefits and patient-reported outcomes over chemotherapy alone.
Read More
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
